The US will pay Moderna $176 million to develop an mRNA pandemic flu vaccine
- The U.S. Government will provide Moderna with $176 million to speed up the development of a pandemic influenza vaccine.
- Moderna's early-stage bird flu vaccine, using mRNA technology like COVID-19 vaccines, receives further funding for continued development and possible late-stage trials.
- The project can pivot to target different influenza strains as needed, ensuring readiness for large-scale production during public health emergencies.
Insights by Ground AI
Does this summary seem wrong?
0 Articles
0 Articles
All
Left
Center
Right
Coverage Details
Total News Sources0
Leaning Left3Leaning Right1Center4Last UpdatedBias Distribution50% Center